Risk prediction models for PTS
| . | SOX-PTS score34 . | Points . | Amin et al35 . | Points . | Méan et al36 . | Points . | 
|---|---|---|---|---|---|---|
| Age, y | — | >56 | 2 | ≥75 | 1 | |
| BMI, kg/m2 | ≥35 | 2 | >30 | 2 | — | |
| DVT anatomy | Iliac DVT | 1 | Iliofemoral DVT | 1 | Multilevel thrombosis | 1 | 
| Signs of preexisting venous insufficiency | Baseline Vilalta score | Varicose veins | 4 | Prior varicose vein surgery | 1 | |
| >14 (severe) | 2 | |||||
| 10-14 (moderate) | 1 | |||||
| N of leg signs and symptoms* | 1 (for each) | |||||
| Other | — | Smoking | 1 | Concomitant antiplatelet/NSAID therapy | 1 | |
| Female sex | 1 | |||||
| Provoked DVT | 1 | |||||
| History of DVT | 1 | |||||
| Risk category | Total score | PTS risk, % | Total score | PTS risk, % | Total score | PTS risk, % | 
| Low | 0 | 6.4 | 0-2 | 10 | 0-3 | 24.4 | 
| 1 | 13.4 | |||||
| Intermediate | 2 | 16.4 | 3-4 | 20 | 4-5 | 38.4 | 
| 3 | 25 | |||||
| High | ≥4 | 30 | ≥5 | 40 | ≥6 | 80.7 | 
| . | SOX-PTS score34 . | Points . | Amin et al35 . | Points . | Méan et al36 . | Points . | 
|---|---|---|---|---|---|---|
| Age, y | — | >56 | 2 | ≥75 | 1 | |
| BMI, kg/m2 | ≥35 | 2 | >30 | 2 | — | |
| DVT anatomy | Iliac DVT | 1 | Iliofemoral DVT | 1 | Multilevel thrombosis | 1 | 
| Signs of preexisting venous insufficiency | Baseline Vilalta score | Varicose veins | 4 | Prior varicose vein surgery | 1 | |
| >14 (severe) | 2 | |||||
| 10-14 (moderate) | 1 | |||||
| N of leg signs and symptoms* | 1 (for each) | |||||
| Other | — | Smoking | 1 | Concomitant antiplatelet/NSAID therapy | 1 | |
| Female sex | 1 | |||||
| Provoked DVT | 1 | |||||
| History of DVT | 1 | |||||
| Risk category | Total score | PTS risk, % | Total score | PTS risk, % | Total score | PTS risk, % | 
| Low | 0 | 6.4 | 0-2 | 10 | 0-3 | 24.4 | 
| 1 | 13.4 | |||||
| Intermediate | 2 | 16.4 | 3-4 | 20 | 4-5 | 38.4 | 
| 3 | 25 | |||||
| High | ≥4 | 30 | ≥5 | 40 | ≥6 | 80.7 | 
BMI, body mass index; NSAID, nonsteroidal antiinflammatory drug.
Pain, cramps, heaviness, pruritus, paraesthesias, edema, skin induration, hyperpigmentation, venous ectasia, redness, and pain during calf compression.